CClinicalTrials.gg
CompletedNCT02816320RNMHUpdated Apr 3, 2019

Validity of Information Employed to Generate Standardized Mortality Ratios Using Hospital Administrative Databases (RNMH)

An observational study in Surgical Condition, Obstetrical Condition and Hospitalization in Acute Care, sponsored by Hospices Civils de Lyon. Completed. Per ClinicalTrials.gov, last updated 2019-04-03.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
715
Sex
All
01

Study summary

In a retrospective cross-sectional study, investigators aimed to valid the variables employed to generate standardized mortality ratio from hospital administrative databases. For this purpose, investigators have compared those variables collected in administrative databases with the information available in patient medical record.

02

Conditions studied

  • Surgical Condition
  • Obstetrical Condition
  • Hospitalization in Acute Care

Browse trials for

Keywords

  • hospital mortality
  • standardized mortality ratios
  • patient safety
  • healthcare quality
  • hospital performance
  • administrative data
03

In context

Disease

1,327 studies on the registry are indexed under Disease; 596 are open to participants now.

This study's enrollment of 715 is above the median of 215 across 573 observational studies indexed under Disease.

Browse Disease studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

A random sample of patients who were hospitalized in 24 participating hospitals during the study period.

Inclusion criteria

  • All inpatients stays in acute care from high mortality diagnosis related groups (DRGs) registered in administrative databases of participating hospitals from January to December 2010.

Exclusion criteria

Exclusion Criteria:

  • Hospital participation refusal
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
715 participants (actual)
Patient registry
No

Groups and cohorts

  • Inpatient stays

    All patients who were hospitalized in participating hospitals in France during the study period were eligible for inclusion.

    Other: Hospitalization

Interventions

  • OtherHospitalization

    Patients who were hospitalized in acute care

06

What researchers measure

Primary outcomes

  1. In-hospital mortality

    Death collected in hospital administrative databases at the end of in patient stay

    Time frame: within 90 days of admission (D90)

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 3, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02816320
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Jun 28, 2016
Start date
Jul 2014
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Apr 3, 2019

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion